BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Diagnosis
28 results:

  • 1. SECTM1 promotes the development of glioblastoma and mesenchymal transition by regulating the TGFβ1/Smad signaling pathway.
    Yao Z; Zhang F; Qi C; Wang C; Mao M; Zhao C; Qi M; Wang Z; Zhou G; Jiang X; Xia H
    Int J Biol Sci; 2024; 20(1):78-93. PubMed ID: 38164182
    [No Abstract]    [Full Text] [Related]  

  • 2. Identification of FXYD6 as the novel biomarker for glioma based on differential expression and DNA methylation.
    Hou W; Cai J; Shen P; Zhang S; Xiao S; You P; Tong Y; Li K; Qi Z; Luo H
    Cancer Med; 2023 Dec; 12(24):22170-22184. PubMed ID: 38093622
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Deoxyhypusine hydroxylase: A novel therapeutic target differentially expressed in short-term vs long-term survivors of glioblastoma.
    Ofek P; Yeini E; Arad G; Danilevsky A; Pozzi S; Luna CB; Dangoor SI; Grossman R; Ram Z; Shomron N; Brem H; Hyde TM; Geiger T; Satchi-Fainaro R
    Int J Cancer; 2023 Aug; 153(3):654-668. PubMed ID: 37141410
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. MAPK9 is Correlated with a Poor Prognosis and Tumor Progression in Glioma.
    Yang X; Jia Q; Liu X; Wu W; Han Y; Zou Z; Li M; Fan D; Song J; Chen L
    Front Biosci (Landmark Ed); 2023 Mar; 28(3):63. PubMed ID: 37005756
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. SLERT, as a novel biomarker, orchestrates endometrial cancer metastasis via regulation of BDNF/TRKB signaling.
    Tian J; Cheng H; Wang N; Wang C
    World J Surg Oncol; 2023 Jan; 21(1):27. PubMed ID: 36721236
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. LncRNA T376626 is a promising serum biomarker and promotes proliferation, migration, and invasion via binding to LAMC2 in triple-negative breast cancer.
    He Y; Xiao B; Lei T; Xuan J; Zhu Y; Kuang Z; Liu J; He J; Li L; Sun Z
    Gene; 2023 Apr; 860():147227. PubMed ID: 36709879
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Proposing Specific Neuronal Epithelial-to-Mesenchymal Transition Genes as an Ancillary Tool for Differential diagnosis among Pulmonary Neuroendocrine Neoplasms.
    Prieto TG; Baldavira CM; Machado-Rugolo J; Olivieri EHR; da Silva ECA; Ab' Saber AM; Takagaki TY; Capelozzi VL
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553576
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A depression network caused by brain tumours.
    Li Y; Jin Y; Wu D; Zhang L
    Brain Struct Funct; 2022 Nov; 227(8):2787-2795. PubMed ID: 36190539
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Stathmin 1 is a biomarker for diagnosis of microvascular invasion to predict prognosis of early hepatocellular carcinoma.
    Cai Y; Fu Y; Liu C; Wang X; You P; Li X; Song Y; Mu X; Fang T; Yang Y; Gu Y; Zhang H; He Z
    Cell Death Dis; 2022 Feb; 13(2):176. PubMed ID: 35210426
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Radiomics analysis allows for precise prediction of silent corticotroph adenoma among non-functioning pituitary adenomas.
    Rui W; Qiao N; Wu Y; Zhang Y; Aili A; Zhang Z; Ye H; Wang Y; Zhao Y; Yao Z
    Eur Radiol; 2022 Mar; 32(3):1570-1578. PubMed ID: 34837512
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. TRAM2 promotes the malignant progression of glioma through PI3K/AKT/mTOR pathway.
    Gao X; Jiang W; Ke Z; Huang Q; Chen L; Zhang G; Li C; Yu X
    Biochem Biophys Res Commun; 2022 Jan; 586():34-41. PubMed ID: 34826698
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Silencing IKBKE inhibits the migration and invasion of glioblastoma by promoting Snail1 degradation.
    Liu Y; Guo G; Lu Y; Chen X; Zhu L; Zhao L; Li C; Zhang Z; Jin X; Dong J; Yang X; Huang Q
    Clin Transl Oncol; 2022 May; 24(5):816-828. PubMed ID: 34741724
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. LINC01116 boosts the progression of pituitary adenoma via regulating miR-744-5p/HOXB8 pathway.
    Huang T; Cai M; Chen C; Ling C; Zhang B; Zheng W; Luo L
    Mol Cell Endocrinol; 2021 Oct; 536():111350. PubMed ID: 34098015
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The Fibronectin Expression Determines the Distinct Progressions of Malignant Gliomas via Transforming Growth Factor-Beta Pathway.
    Chen CW; Yang CH; Lin YH; Hou YC; Cheng TJ; Chang ST; Huang YH; Chung ST; Chio CC; Shan YS; Cheng HC; Chang WT
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917452
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Heterotopic ossification in lymph node metastasis after rectal cancer resection: a case report and literature review.
    Nagano H; Togawa T; Watanabe T; Ohnishi K; Kimura T; Iida A; Noriki S; Imamura Y; Sato Y; Goi T
    World J Surg Oncol; 2021 Jan; 19(1):2. PubMed ID: 33388078
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Single-cell transcriptome analysis demonstrates inter-patient and intra-tumor heterogeneity in primary and metastatic lung adenocarcinoma.
    Liu Y; Ye G; Huang L; Zhang C; Sheng Y; Wu B; Han L; Wu C; Dong B; Qi Y
    Aging (Albany NY); 2020 Nov; 12(21):21559-21581. PubMed ID: 33170151
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. TWIST1 upregulation affects E-cadherin expression in brain metastases.
    Brlek P; Bukovac A; Kafka A; Pećina-Šlaus N
    Clin Transl Oncol; 2021 Jun; 23(6):1085-1095. PubMed ID: 33006113
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Rhoj Is a Novel Target for Progression and Invasion of Glioblastoma by Impairing Cytoskeleton Dynamics.
    Wang M; Jiang X; Yang Y; Chen H; Zhang C; Xu H; Qi B; Yao C; Xia H
    Neurotherapeutics; 2020 Oct; 17(4):2028-2040. PubMed ID: 32822001
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. CircPTK2 (hsa_circ_0005273) as a novel therapeutic target for metastatic colorectal cancer.
    Yang H; Li X; Meng Q; Sun H; Wu S; Hu W; Liu G; Li X; Yang Y; Chen R
    Mol Cancer; 2020 Jan; 19(1):13. PubMed ID: 31973707
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme.
    Ho KH; Cheng CH; Chou CM; Chen PH; Liu AJ; Lin CW; Shih CM; Chen KC
    Pharmacol Res; 2019 Sep; 147():104390. PubMed ID: 31398406
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.